Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
Park, Y H, Jung, H A, Choi, M K, Chang, W, Choi, Y L, Do, I-g, Ahn, J S, Im, Y-HVolume:
110
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.757
Date:
January, 2014
File:
PDF, 1.25 MB
english, 2014